Press for TearScience

TearScience, Inc., a venture funded medical device company, today announced that Duke Eye Center, an academic research and education-based university eye care center, has purchased TearScience’s LipiFlow® Thermal Pulsation System, a breakthrough treatment for evaporative dry eye disease and meibomian gland dysfunction. Duke Eye Center focuses on the latest technology, research, and education to provide the most advanced patient care, including the management of dry eye disease.

TearScience, Inc., a privately-held medical device company, today announced that Fayetteville, North Carolina-based Carolina Vision Center, is the first eye care center in United States to commercially offer the LipiFlow® Thermal Pulsation System, a breakthrough treatment for evaporative dry eye disease. TearScience’s LipiFlow is designed to address meibomian gland dysfunction, allowing for the treatment of eyelid gland blockages during a non-invasive procedure administered at an eye care office. Opening the blocked eyelid glands allows the glands to resume the natural production of lipids (oils) needed for a healthy tear film. TearScience received U.S. FDA clearance for its LipiFlow® medical device on June 28, 2011.

TearScience, a Morrisville medical device company, has raised $15 million in debt financing that it plans to use to commercialize the company's treatment for dry-eye disease.
The company raised the money from Oxford Finance and Silicon Valley Bank.

TearScience®, Inc., a privately-held medical device company, today announced that it has appointed Diethart Reichardt as senior vice president of the European region including Europe, Middle East and Africa. In this role, Reichardt will be responsible for sales, marketing, operations and customer service teams based in the European region as well as a distributor network in Africa and the Middle East. Reichardt will be based in Germany. TearScience’s advanced solutions are designed to help eye care physicians treat patients suffering from evaporative dry eye disease and Meibomian Gland Dysfunction.